Caco-2 Intestinal Permeability Study of Phenyltetrahydroquinolinedione Derivative – TRPA₁ Antagonist
Introduction. This work is devoted to the intestinal permeability study of 7-(2-chlorophenyl)-4-(4-methyl-1,3-thiazol-5-yl)-4,6,7,8-tetrahydroquinoline-2,5(1H,3H)-dione – innovative biologically active substance with TRPA1 antagonist activity. The phenyltetrahydroquinolinedione derivative is a promi...
Saved in:
| Main Authors: | N. V. Pyatigorskaya, A. D. Kravchenko |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
LLC Center of Pharmaceutical Analytics (LLC «CPHA»)
2022-09-01
|
| Series: | Разработка и регистрация лекарственных средств |
| Subjects: | |
| Online Access: | https://www.pharmjournal.ru/jour/article/view/1301 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Propofol reduces human TRPA1 activity in a warm environment
by: Chihiro Suda, et al.
Published: (2025-03-01) -
Binding and Activating of Analgesic Crotalphine with Human TRPA1
by: Mingmin Kang, et al.
Published: (2025-06-01) -
The Potential of TRPA1 as a Therapeutic Target in Cancer—A Study Using Bioinformatic Tools
by: Dana Cucu
Published: (2024-12-01) -
Insights into the Involvement of TRPA1 Channels in the Neuro-Inflammatory Machinery of Trigeminal Neuralgia
by: Chiara Demartini, et al.
Published: (2025-04-01) -
Proof of Pharmacology, Safety, and Pharmacokinetics of the Novel TRPA1 Antagonist BI 1839100: A Randomized, Placebo‐Controlled, Parallel Group, First‐In‐Human Study in Healthy Male Participants
by: Marella C. E. vanRuissen, et al.
Published: (2025-08-01)